UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hypoxia-Induced Autophagy Promotes Tumor Cell Survival and Adaptation to Antiangiogenic Treatment in Glioblastoma

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (7), p.1773-1783

2012

Volltextzugriff (PDF)

The vascular basement membrane as "soil" in brain metastasis

PloS one, 2009-06, Vol.4 (6), p.e5857-e5857

2009

Volltextzugriff (PDF)

Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance

Clinical cancer research, 2013-04, Vol.19 (7), p.1773-1783

2013

Volltextzugriff (PDF)

β1 Integrin Targeting Potentiates Antiangiogenic Therapy and Inhibits the Growth of Bevacizumab-Resistant Glioblastoma

Cancer research (Chicago, Ill.), 2013-05, Vol.73 (10), p.3145-3154

2013

Volltextzugriff (PDF)

β1 Integrin: Critical Path to Antiangiogenic Therapy Resistance and Beyond

Cancer research (Chicago, Ill.), 2014-01, Vol.74 (1), p.3-7

2014

Volltextzugriff (PDF)

Microarray Analysis Verifies Two Distinct Phenotypes of Glioblastomas Resistant to Antiangiogenic Therapy

Clinical cancer research, 2012-05, Vol.18 (10), p.2930-2942

2012

Volltextzugriff (PDF)

Molecular MRI enables early and sensitive detection of brain metastases

Proceedings of the National Academy of Sciences - PNAS, 2012-04, Vol.109 (17), p.6674-6679

2012

Volltextzugriff (PDF)

Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966

Scientific reports, 2019-01, Vol.9 (1), p.1030-1030, Article 1030

2019

Volltextzugriff (PDF)

Endpoint in ovarian cancer xenograft model predicted by nighttime motion metrics

Lab animal, 2020-08, Vol.49 (8), p.227-232

2020

Volltextzugriff (PDF)

Abstract A21: Digital vivarium cloud platform facilitates nonclinical endpoint assessment in an ovarian carcinoma xenograft model with ascites

Clinical cancer research, 2020-07, Vol.26 (13_Supplement), p.A21-A21

2020

Volltextzugriff (PDF)

Regional and temporal characterization of neuronal, glial, and axonal response after traumatic brain injury in the mouse

Acta neuropathologica, 1999-10, Vol.98 (4), p.396-406

1999

Volltextzugriff (PDF)

ACTR-55. OPTIMIZED TREAT-RESECT-TREAT STUDY DESIGN FOR CONVECTION-ENHANCED DELIVERY OF A FIRST-IN-CLASS BIOLOGIC IN THE TREATMENT OF GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi26-vi26

2019

Volltextzugriff (PDF)

Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966

Molecular cancer therapeutics, 2019-06, Vol.18 (6), p.1127-1136

2019

Volltextzugriff (PDF)

Nonclinical endpoint assessment utilizing a digital vivarium cloud platform in an ovarian cancer xenograft model

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14690-e14690

2019

Volltextzugriff (PDF)

Infiltrative microgliosis: activation and long-distance migration of subependymal microglia following periventricular insults

Journal of neuroinflammation, 2005-01, Vol.2 (1), p.5-5

2005

Volltextzugriff (PDF)

Migration of Perilesional Microglia after Focal Brain Injury and Modulation by CC Chemokine Receptor 5: An In Situ Time-Lapse Confocal Imaging Study

The Journal of neuroscience, 2005-07, Vol.25 (30), p.7040-7047

2005

Volltextzugriff (PDF)

A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade Meningioma

Targeted oncology, 2019-08, Vol.14 (4), p.479-489

2019

Volltextzugriff (PDF)

Adaptation of the fluid percussion injury model to the mouse

Journal of neurotrauma, 1998-03, Vol.15 (3), p.217-229

1998

Volltextzugriff (PDF)

CSIG-33. BETA 1 INTEGRIN INHIBITION IN HIGH-GRADE MENINGIOMA

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi56-vi56

2017

Volltextzugriff (PDF)

Transient neuronal but persistent astroglial activation of ERK/MAP kinase after focal brain injury in mice

Journal of neurotrauma, 2003-04, Vol.20 (4), p.327-336

2003

Volltextzugriff (PDF)

How Do We Fuel the Rise of the Scientist-CEO?

GEN biotechnology (Print), 2022-10, Vol.1 (5), p.440-443

2022

Volltextzugriff (PDF)

EXTH-33. OS2966 DRAMATICALLY ENHANCES PRECLINICAL EFFICACY OF ONCOLYTIC VIRUS THERAPY

Neuro-oncology (Charlottesville, Va.), 2016-11, Vol.18 (suppl_6), p.vi66-vi66

2016

Volltextzugriff (PDF)

Evidence Disputing the Importance of Excitotoxicity in Hippocampal Neuron Death after Experimental Traumatic Brain Injury

Annals of the New York Academy of Sciences, 1999-01, Vol.890 (1), p.287-298

1999

Volltextzugriff (PDF)

DRES-08. A NOVEL XENOGRAFT MODEL REVEALS A GENE CASCADE AND SERUM BIOMARKER DEFINING A MESENCHYMAL TRANSITION DURING THE EVOLUTION OF GLIOBLASTOMA RESISTANCE TO ANTI-ANGIOGENIC THERAPY

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi65-vi65

2017

Volltextzugriff (PDF)

Abstract 2312: Targeting beta1 integrin potentiates antiangiogenic therapy and inhibits growth of bevacizumab-resistant glioblastoma multiforme

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.2312-2312

2013

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(31)
Dissertationen
(1)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Animals
(14)
Life Sciences & Biomedicine
(13)
Mice
(13)
Humans
(10)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Cell Line, Tumor
(7)
Neurosciences
(6)
Neurosciences & Neurology
(6)
Tumors
(6)
Antibodies, Monoclonal, Humanized - Therapeutic Use
(5)
Antineoplastic Agents
(5)
Brain Neoplasms - Pathology
(5)
Male
(5)
Mice, Inbred C57bl
(5)
Oncology
(5)
Pharmacology. Drug Treatments
(5)
Angiogenesis Inhibitors - Therapeutic Use
(4)
Bevacizumab
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hypoxia-Induced Autophagy Promotes Tumor Cell Survival and Adaptation to Antiangiogenic Treatment in Glioblastoma

The vascular basement membrane as "soil" in brain metastasis

Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance

β1 Integrin Targeting Potentiates Antiangiogenic Therapy and Inhibits the Growth of Bevacizumab-Resistant Glioblastoma

β1 Integrin: Critical Path to Antiangiogenic Therapy Resistance and Beyond

Microarray Analysis Verifies Two Distinct Phenotypes of Glioblastomas Resistant to Antiangiogenic Therapy

Molecular MRI enables early and sensitive detection of brain metastases

Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966

Endpoint in ovarian cancer xenograft model predicted by nighttime motion metrics

Abstract A21: Digital vivarium cloud platform facilitates nonclinical endpoint assessment in an ovarian carcinoma xenograft model with ascites

Regional and temporal characterization of neuronal, glial, and axonal response after traumatic brain injury in the mouse

ACTR-55. OPTIMIZED TREAT-RESECT-TREAT STUDY DESIGN FOR CONVECTION-ENHANCED DELIVERY OF A FIRST-IN-CLASS BIOLOGIC IN THE TREATMENT OF GLIOBLASTOMA

Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966

Nonclinical endpoint assessment utilizing a digital vivarium cloud platform in an ovarian cancer xenograft model

Infiltrative microgliosis: activation and long-distance migration of subependymal microglia following periventricular insults

Migration of Perilesional Microglia after Focal Brain Injury and Modulation by CC Chemokine Receptor 5: An In Situ Time-Lapse Confocal Imaging Study

A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade Meningioma

Adaptation of the fluid percussion injury model to the mouse

CSIG-33. BETA 1 INTEGRIN INHIBITION IN HIGH-GRADE MENINGIOMA

Transient neuronal but persistent astroglial activation of ERK/MAP kinase after focal brain injury in mice

How Do We Fuel the Rise of the Scientist-CEO?

EXTH-33. OS2966 DRAMATICALLY ENHANCES PRECLINICAL EFFICACY OF ONCOLYTIC VIRUS THERAPY

Evidence Disputing the Importance of Excitotoxicity in Hippocampal Neuron Death after Experimental Traumatic Brain Injury

DRES-08. A NOVEL XENOGRAFT MODEL REVEALS A GENE CASCADE AND SERUM BIOMARKER DEFINING A MESENCHYMAL TRANSITION DURING THE EVOLUTION OF GLIOBLASTOMA RESISTANCE TO ANTI-ANGIOGENIC THERAPY

Abstract 2312: Targeting beta1 integrin potentiates antiangiogenic therapy and inhibits growth of bevacizumab-resistant glioblastoma multiforme

Suchergebnisse filtern